---
title: "Zhongheng Group's subsidiary Wuzhou Pharmaceutical plans to be selected for the centralized bulk purchasing of traditional Chinese medicine by the National Traditional Chinese Medicine Procurement Alliance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229393249.md"
description: "Zhongheng Group's subsidiary Guangxi Wuzhou Pharmaceutical participated in the national Chinese patent medicine procurement alliance's centralized bulk procurement, with the product Thrombin Injection (Lyophilized) expected to be selected"
datetime: "2025-02-24T09:46:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229393249.md)
  - [en](https://longbridge.com/en/news/229393249.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229393249.md)
---

# Zhongheng Group's subsidiary Wuzhou Pharmaceutical plans to be selected for the centralized bulk purchasing of traditional Chinese medicine by the National Traditional Chinese Medicine Procurement Alliance

According to the announcement from Zhongheng Group (600252.SH), the company's controlling subsidiary Guangxi Wuzhou Pharmaceutical (Group) Co., Ltd. (referred to as "Wuzhou Pharmaceutical") participated in the national traditional Chinese medicine procurement alliance's centralized bulk procurement work. Recently, according to the announcement from the National Traditional Chinese Medicine Joint Procurement Office regarding the public notice of the proposed selected and non-quoted representative products for the centralized procurement of the national traditional Chinese medicine procurement alliance, Wuzhou Pharmaceutical's product, Thrombin Injection (Lyophilized), is proposed to be selected as a non-quoted representative product for this national traditional Chinese medicine procurement alliance's centralized bulk procurement, with the proposed selected product being Thrombin Injection (Lyophilized)

### Related Stocks

- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [Instagram introduces a redesigned wordmark](https://longbridge.com/en/news/295822098.md)
- [REG - Odyssean Inv. Trust - Issue of Equity](https://longbridge.com/en/news/295683790.md)
- [Grubhub’s $24M FTC settlement is finally reaching diners and drivers](https://longbridge.com/en/news/295698459.md)
- [SMIC posts earnings beat as mature-node orders surge](https://longbridge.com/en/news/295783422.md)
- [13:00 ETAnecdotes Extends Agentic GRC to Third-Party Risk Management](https://longbridge.com/en/news/295692877.md)